ProShare Advisors LLC
- SEC CIK
- 0001357955
- Latest filing
- Aug 11, 2026
TSHA holding history
Taysha Gene Therapies, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TSHA overviewAll 13F holders of TSHAFull Q2 2026 holdings
- Shares (Q2 2026)
- 40,817
- Value
- $278.0K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 40,817 | $278.0K | <0.1% | −3,450−7.8% | Reduced | Holders |
| Q1 2026 | 44,267 | $197.9K | <0.1% | −8,196−15.6% | Reduced | Holders |
| Q4 2025 | 52,463 | $288.5K | <0.1% | +6,424+14.0% | Added | Holders |
| Q3 2025 | 46,039 | $150.5K | <0.1% | +2,293+5.2% | Added | Holders |
| Q2 2025 | 43,746 | $101.1K | <0.1% | −3,449−7.3% | Reduced | Holders |
| Q1 2025 | 47,195 | $65.6K | <0.1% | −11,881−20.1% | Reduced | Holders |
| Q4 2024 | 59,076 | $102.2K | <0.1% | +14,418+32.3% | Added | Holders |
| Q3 2024 | 44,658 | $89.8K | <0.1% | +33,113+286.8% | Added | Holders |
| Q2 2024 | 11,545 | $25.9K | <0.1% | −1,558−11.9% | Reduced | Holders |
| Q1 2024 | 13,103 | $37.6K | <0.1% | +1,157+9.7% | Added | Holders |
| Q4 2023 | 11,946 | $21.1K | <0.1% | +11,946 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −10,368−100.0% | Sold out | Holders |
| Q4 2021 | 10,368 | $121.0K | <0.1% | +10,368 | New | Holders |